Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Truveta

Truveta achieves HITRUST r2 Certification, demonstrating the highest level of information protection assurance
From Truveta
Via GlobeNewswire
Truveta Data, the most complete, timely, and clean electronic health record data, now includes more than 120 million de-identified patients
From Truveta
Via GlobeNewswire
Truveta Studio now includes Truveta Tru, a research assistant powered by generative AI
From Truveta
Via GlobeNewswire
The CHOICE Institute partners with Truveta to advance health economics and outcomes research
From Truveta
Via GlobeNewswire
Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss published in JAMA Internal Medicine
From Truveta
Via GlobeNewswire
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
From Truveta
Via GlobeNewswire
Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair
From Truveta
Via GlobeNewswire
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance research
From Truveta
Via GlobeNewswire
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
From Truveta
Via GlobeNewswire
CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care
From Truveta
Via GlobeNewswire
Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics
From Truveta
Via GlobeNewswire
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
From Truveta
Via GlobeNewswire
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
From Truveta
Via GlobeNewswire
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
From Truveta
Via GlobeNewswire
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI
From Truveta
Via GlobeNewswire
Truveta advances security and privacy with Type 2 SOC 2 examination
From Truveta
Via GlobeNewswire
Truveta and Mathematica partner to advance public health and health equity with real-world data
From Truveta
Via GlobeNewswire
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
From Truveta
Via GlobeNewswire
Truveta Data now includes medication dispense data to help address nation’s 7th leading cause of death
From Truveta
Via GlobeNewswire
Truveta community expands to more than 40 healthcare and life science organizations with a shared mission of saving lives with data
From Truveta
Via GlobeNewswire
Truveta collaboration with Harvard University researchers published in JAMA Network Open
From Truveta
Via GlobeNewswire
Truveta Language Model unlocks EHR data for the most complete and accurate medical research
From Truveta
Via GlobeNewswire
Truveta and Alpine Immune Sciences Announce Strategic Partnership to Access Truveta’s Community to Accelerate Recruitment to Povetacicept Clinical Trials
From Truveta
Via GlobeNewswire
New SDOH data in Truveta Studio provide most complete view of health equity’s influence on patient health and outcomes
From Truveta
Via GlobeNewswire
Truveta’s COVID-19 breakthrough infections research published in Vaccine
From Truveta
Via GlobeNewswire
New Research: Preeclampsia-related heart failure disproportionately impacts Black mothers
From Truveta
Via GlobeNewswire
Truveta expands with three new US health system members
From Truveta
Via GlobeNewswire
Truveta Research shares new insights on RSV hospitalization trends
From Truveta
Via GlobeNewswire
Truveta’s COVID-19 health equity research published in Frontiers in Public Health
From Truveta
Via GlobeNewswire
Truveta Studio delivers the health data and analytics the world deserves now
From Truveta
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.